|
35
|
Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract
HT942626RE002 · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY · other
|
biomedical clinical
public health
national security defense
|
— |
2026-01-30 |
— |
— |
|
25
|
A--To Expand the Workscope of the PACT III Program
75N92018R0070 · · service delivery
|
biomedical clinical
public health
|
— |
2018-08-09 |
— |
— |
|
18
|
Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract
HT942626RE002 · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY · applied research
|
biomedical clinical
public health
national security defense
|
— |
2026-06-30 |
— |
— |
|
16
|
Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract
HT942626RE002 · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY · applied research
|
biomedical clinical
public health
education workforce
|
— |
2026-08-17 |
— |
— |
|
15
|
Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract
HT942626RE002 · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY · applied research
|
biomedical clinical
public health
national security defense
|
— |
2026-05-29 |
— |
— |
|
15
|
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
W911SR-26-R-HEAL · DEPT OF THE ARMY · W6QK ACC-APG · commercialization
|
biomedical clinical
national security defense
public health
|
— |
2026-05-06 |
— |
— |
|
15
|
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
W911SR-26-R-HEAL · DEPT OF THE ARMY · W6QK ACC-APG · commercialization
|
national security defense
biomedical clinical
public health
|
— |
2026-04-23 |
— |
— |
|
15
|
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
W911SR-26-R-HEAL · DEPT OF DEFENSE · applied research
|
national security defense
biomedical clinical
public health
|
— |
2026-04-23 |
— |
— |
|
15
|
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
· DEPT OF DEFENSE · commercialization
|
national security defense
biomedical clinical
public health
|
— |
2026-04-23 |
— |
— |
|
15
|
Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract
HT942626RE002 · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY · applied research
|
biomedical clinical
public health
education workforce
|
— |
2026-03-04 |
— |
— |
|
15
|
Vendor Collaboration - MULTI-CENTER CLINICAL TRIALS OF NOVEL THERAPIES FOR PATIENTS WITH WELL CHARACTERIZED GASTROPARESIS
NIDDK2017-0001 · · evaluation research
|
biomedical clinical
public health
|
— |
2017-06-14 |
— |
— |
|
15
|
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
W911SR-26-R-HEAL · DEPT OF THE ARMY · W6QK ACC-APG · applied research
|
biomedical clinical
national security defense
materials manufacturing
|
— |
2026-07-21 |
— |
— |
|
12
|
Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract
HT942626RE002 · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY · applied research
|
biomedical clinical
public health
national security defense
|
— |
2026-01-12 |
— |
— |
|
12
|
A--to expand the scope of the program by re-introducing the manufacture and distri
75N92018R0070 · · service delivery
|
biomedical clinical
public health
|
— |
2018-08-03 |
— |
— |
|
12
|
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
W911SR-26-R-HEAL · DEPT OF THE ARMY · W6QK ACC-APG · applied research
|
biomedical clinical
public health
national security defense
|
— |
2026-08-05 |
— |
— |
|
10
|
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
W911SR-26-R-HEAL · DEPT OF THE ARMY · W6QK ACC-APG · applied research
|
biomedical clinical
national security defense
public health
|
— |
2026-08-19 |
— |
— |
|
8
|
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
W911SR-26-R-HEAL · DEPT OF DEFENSE · applied research
|
national security defense
biomedical clinical
public health
|
— |
2026-04-23 |
— |
— |
|
8
|
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
W911SR-26-R-HEAL · DEPT OF THE ARMY · W6QK ACC-APG · applied research
|
public health
biomedical clinical
national security defense
|
— |
2026-08-19 |
— |
— |